"Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer: A Pre-Planned Interim Analysis" by Federico Albrecht

Presentation

Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer: A Pre-Planned Interim Analysis

All Publications

Federico Albrecht, Miami Cancer Institute
Rupesh Kotecha, Miami Cancer Institute
Zhenwei Zhang, Baptist Health South Florida

Publication Date

8-6-2022

Presented At:

IASLC 2022 World Conference on Lung Cancer

Content Type

Poster

Additional Authors:

Additional authors and institutional affiliations

Citation Information

Federico Albrecht, Rupesh Kotecha and Zhenwei Zhang. "Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer: A Pre-Planned Interim Analysis" (2022)
Available at: http://works.bepress.com/federico-albrecht/22/